Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $420,359.49 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $15.43, for a total value of $420,359.49. Following the transaction, the president now owns 2,276,732 shares of the company’s stock, valued at $35,129,974.76. This trade represents a 1.18 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Trading Up 1.9 %

Shares of ALHC stock opened at $15.79 on Friday. The company’s fifty day simple moving average is $14.38 and its two-hundred day simple moving average is $12.43. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $16.25. The stock has a market capitalization of $3.03 billion, a price-to-earnings ratio of -20.51 and a beta of 1.49.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on ALHC shares. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Barclays lifted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research report on Friday, February 28th. Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Bank of America lifted their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $14.83.

Institutional Investors Weigh In On Alignment Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Mackenzie Financial Corp raised its holdings in Alignment Healthcare by 149.8% during the 4th quarter. Mackenzie Financial Corp now owns 85,175 shares of the company’s stock valued at $958,000 after acquiring an additional 51,084 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Alignment Healthcare by 15.9% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,203 shares of the company’s stock valued at $2,961,000 after purchasing an additional 36,151 shares in the last quarter. Voloridge Investment Management LLC purchased a new position in shares of Alignment Healthcare during the 4th quarter valued at $189,000. Squarepoint Ops LLC grew its position in shares of Alignment Healthcare by 414.6% during the 4th quarter. Squarepoint Ops LLC now owns 198,309 shares of the company’s stock valued at $2,231,000 after purchasing an additional 159,774 shares in the last quarter. Finally, Two Sigma Investments LP purchased a new position in shares of Alignment Healthcare during the 4th quarter valued at $258,000. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.